300841 康華生物
按盤價 
52.800 +1.200 (+2.326%)
52.800 +1.200 (+2.326%) | 2024/03 - 三個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 4.201 | 15.455 | 20.817 | 35.717 | 32.015 |
| 總資產報酬率 ROA (%) | 3.554 | 12.858 | 17.776 | 32.115 | 28.768 |
| 投入資產回報率 ROIC (%) | 3.968 | 14.665 | 20.247 | 35.622 | 31.836 | 邊際利潤分析 |
| 銷售毛利率 (%) | 95.847 | 93.524 | 93.562 | 93.520 | 93.949 |
| 營業利潤率 (%) | 55.290 | 36.555 | 47.383 | 70.855 | 46.702 |
| 息稅前利潤/營業總收入 (%) | 54.579 | 35.885 | 46.507 | 69.205 | 45.424 |
| 淨利潤/營業總收入 (%) | 48.003 | 32.282 | 41.339 | 64.179 | 39.287 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 102.537 | 107.690 | 97.339 | 70.491 | 98.774 |
| 價值變動淨收益/利潤總額(%) | 0.356 | -5.444 | 8.322 | 29.924 | 0.459 |
| 營業外收支淨額/利潤總額(%) | -0.006 | -0.456 | -0.250 | -0.020 | -0.232 | 償債能力分析 |
| 流動比率 (X) | 4.493 | 3.897 | 3.507 | 5.731 | 10.448 |
| 速動比率 (X) | 4.172 | 3.643 | 3.256 | 5.420 | 10.155 |
| 資產負債率 (%) | 14.295 | 16.516 | 17.122 | 11.522 | 0.081 |
| 帶息債務/全部投入資本 (%) | 5.349 | 5.086 | 4.473 | 0.022 | 0.000 |
| 股東權益/帶息債務 (%) | 1,763.689 | 1,859.192 | 2,130.120 | 449,460.361 | -- |
| 股東權益/負債合計 (%) | 599.534 | 505.461 | 484.054 | 767.900 | 1,139.684 |
| 利息保障倍數 (X) | -77.082 | -71.230 | -61.344 | -42.318 | -38.835 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 400.644 | 307.828 | 264.297 | 165.712 | 109.038 |
| 存貨周轉天數 (天) | 1,261.886 | 576.539 | 500.834 | 334.013 | 282.245 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 26/06/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
